Century Therapeutics CFO Michael Diem resigns; Douglas Carr named interim CFO

Century Therapeutics, Inc.

CFO Michael C. Diem resigned effective Feb 2, 2024; company has initiated a search for a permanent replacement.
Douglas Carr, SVP Finance and Operations, will serve as interim principal financial officer following Dr. Diem's departure.
Dr. Diem's resignation is not due to any disagreement with the company's operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Douglas Carr

interim Principal Financial Officer

IPSC · Century Therapeutics, Inc.

Effective: 2024-02-02
Filed: January 19, 2024, 6:59 PM ET

Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.

Departed

Michael C. Diem

Chief Financial Officer

IPSC · Century Therapeutics, Inc.

Effective: 2024-02-02
Successor: Douglas Carr
Filed: January 19, 2024, 6:59 PM ET

On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Douglas Carr was appointed as interim Principal Financial Officer at Century Therapeutics, Inc..

Action: appointed
Role: interim Principal Financial Officer

Exact text from the filing

Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael C. Diem resigned as Chief Financial Officer at Century Therapeutics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.

View on SEC.gov

Century Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-005271

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.